CN103608023A - 磷虾油的胃肠外治疗应用 - Google Patents

磷虾油的胃肠外治疗应用 Download PDF

Info

Publication number
CN103608023A
CN103608023A CN201280028987.7A CN201280028987A CN103608023A CN 103608023 A CN103608023 A CN 103608023A CN 201280028987 A CN201280028987 A CN 201280028987A CN 103608023 A CN103608023 A CN 103608023A
Authority
CN
China
Prior art keywords
pharmaceutical composition
oil
drug
composition according
krill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280028987.7A
Other languages
English (en)
Chinese (zh)
Inventor
大卫·F·德里斯科尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stable Solutions LLC
Original Assignee
Stable Solutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/161,101 external-priority patent/US8895074B2/en
Application filed by Stable Solutions LLC filed Critical Stable Solutions LLC
Priority to CN201710990052.1A priority Critical patent/CN107648268B/zh
Publication of CN103608023A publication Critical patent/CN103608023A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201280028987.7A 2011-06-15 2012-06-13 磷虾油的胃肠外治疗应用 Pending CN103608023A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710990052.1A CN107648268B (zh) 2011-06-15 2012-06-13 磷虾油的胃肠外治疗应用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/161,101 2011-06-15
US13/161,101 US8895074B2 (en) 2011-06-15 2011-06-15 Therapeutic application of parenteral krill oil
EP11179821.1 2011-09-02
EP11179821 2011-09-02
PCT/IB2012/001156 WO2012172411A1 (en) 2011-06-15 2012-06-13 Therapeutic application of parenteral krill oil

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201710990052.1A Division CN107648268B (zh) 2011-06-15 2012-06-13 磷虾油的胃肠外治疗应用

Publications (1)

Publication Number Publication Date
CN103608023A true CN103608023A (zh) 2014-02-26

Family

ID=46456944

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201280028987.7A Pending CN103608023A (zh) 2011-06-15 2012-06-13 磷虾油的胃肠外治疗应用
CN201710990052.1A Expired - Fee Related CN107648268B (zh) 2011-06-15 2012-06-13 磷虾油的胃肠外治疗应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201710990052.1A Expired - Fee Related CN107648268B (zh) 2011-06-15 2012-06-13 磷虾油的胃肠外治疗应用

Country Status (22)

Country Link
EP (1) EP2720701B1 (enExample)
JP (1) JP5864735B2 (enExample)
KR (1) KR101841588B1 (enExample)
CN (2) CN103608023A (enExample)
BR (1) BR112013032224B1 (enExample)
CA (1) CA2838312C (enExample)
CY (1) CY1119417T1 (enExample)
DK (1) DK2720701T3 (enExample)
ES (1) ES2643843T3 (enExample)
HR (1) HRP20171431T1 (enExample)
HU (1) HUE036720T2 (enExample)
IL (1) IL229690A (enExample)
LT (1) LT2720701T (enExample)
MX (1) MX351895B (enExample)
PL (1) PL2720701T3 (enExample)
PT (1) PT2720701T (enExample)
RS (1) RS56394B1 (enExample)
RU (1) RU2625760C2 (enExample)
SI (1) SI2720701T1 (enExample)
SM (1) SMT201700470T1 (enExample)
TW (1) TWI592160B (enExample)
WO (1) WO2012172411A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105901740A (zh) * 2016-04-26 2016-08-31 济南极源生物科技有限公司 一种南极磷虾油可食用营养品
CN107567331A (zh) * 2015-03-31 2018-01-09 费森尤斯卡比德国有限公司 用于肠胃外给药的乳液

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2912052C (en) * 2013-05-10 2021-12-14 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers
GB201402450D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Liquid phospholipid-containing compositions for preperation of pharmaceuticals
GB201402457D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Capsules containing high doses of phospholipids
GB201407345D0 (en) 2014-04-25 2014-06-11 Aker Biomarine As Krill Phospholipid compositions
CN106535650A (zh) * 2014-04-30 2017-03-22 恩兹莫特克有限公司 磷虾油制剂和它们的用途
WO2016097854A1 (en) 2014-12-19 2016-06-23 Aker Biomarine Antarctic As Enhanced omega-3 formulations
SG11202000592WA (en) * 2017-08-10 2020-02-27 Childrens Medical Ct Corp Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
EP3536332A1 (en) * 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
KR102451162B1 (ko) * 2020-09-07 2022-10-06 (주)에스디생명공학 효소처리 크릴 오일 추출물을 유효성분으로 포함하는 항염증, 피부 주름개선, 보습 및 피부 재생 촉진용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078625A1 (en) * 2004-10-08 2006-04-13 Susie Rockway Compositions including krill extracts and conjugated linoleic acid and methods of using same
EP2153736A1 (en) * 2007-05-11 2010-02-17 Bizen Chemical Co., Ltd. Novel leukotriene receptor antagonist

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
JPH08231391A (ja) * 1995-02-24 1996-09-10 Kanagawa Kagaku Kenkyusho:Kk 痴呆症状改善薬
CA2313024C (en) * 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
GB0012597D0 (en) * 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
DK1406641T3 (da) * 2001-06-18 2009-05-04 Neptune Technologies & Bioress Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
CN101321477A (zh) * 2005-10-07 2008-12-10 加拿大海洋营养食品有限公司 脂肪酸盐及其制备和使用方法
WO2008060163A1 (en) * 2006-11-16 2008-05-22 Pronova Biopharma Norge As Process for production of omega-3 rich marine phospholipids from krill
FI2144618T4 (fi) * 2007-03-28 2025-02-13 Aker Biomarine Antarctic As Biovaikuttavat krilliöljykoostumukset
NO327925B1 (no) * 2007-06-25 2009-10-19 Pharmalogica As Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene.
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US20100130619A1 (en) * 2008-11-24 2010-05-27 Joseph Schwarz Pharmaceutical composition for parenteral administration of idebenone
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
CA2779334C (en) * 2009-10-30 2017-05-30 Tharos Ltd. Solvent-free process for obtaining phospholipids and neutral enriched krill oils

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078625A1 (en) * 2004-10-08 2006-04-13 Susie Rockway Compositions including krill extracts and conjugated linoleic acid and methods of using same
EP2153736A1 (en) * 2007-05-11 2010-02-17 Bizen Chemical Co., Ltd. Novel leukotriene receptor antagonist

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
施佳慧等: "磷虾油的脂肪酸成分及其降血脂功能研究", 《营养学报》 *
王建中等: "海洋鱼油β-环糊精包合物中EPA和DHA含量的测定", 《无锡轻工大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107567331A (zh) * 2015-03-31 2018-01-09 费森尤斯卡比德国有限公司 用于肠胃外给药的乳液
CN105901740A (zh) * 2016-04-26 2016-08-31 济南极源生物科技有限公司 一种南极磷虾油可食用营养品

Also Published As

Publication number Publication date
CA2838312C (en) 2019-01-08
TWI592160B (zh) 2017-07-21
IL229690A (en) 2017-01-31
HRP20171431T1 (hr) 2017-12-15
RS56394B1 (sr) 2017-12-29
JP2014517028A (ja) 2014-07-17
CA2838312A1 (en) 2012-12-20
PL2720701T3 (pl) 2018-01-31
RU2625760C2 (ru) 2017-07-18
EP2720701A1 (en) 2014-04-23
CY1119417T1 (el) 2018-03-07
KR20140053957A (ko) 2014-05-08
WO2012172411A1 (en) 2012-12-20
RU2014101067A (ru) 2015-07-20
TW201302209A (zh) 2013-01-16
DK2720701T3 (en) 2017-10-30
JP5864735B2 (ja) 2016-02-17
BR112013032224A2 (pt) 2016-12-20
LT2720701T (lt) 2017-11-10
CN107648268B (zh) 2021-06-22
KR101841588B1 (ko) 2018-03-26
ES2643843T3 (es) 2017-11-24
HUE036720T2 (hu) 2018-07-30
BR112013032224B1 (pt) 2021-10-13
IL229690A0 (en) 2014-01-30
EP2720701B1 (en) 2017-08-09
CN107648268A (zh) 2018-02-02
SI2720701T1 (sl) 2017-12-29
MX351895B (es) 2017-11-01
MX2013014901A (es) 2014-07-09
PT2720701T (pt) 2017-10-23
SMT201700470T1 (it) 2018-01-11

Similar Documents

Publication Publication Date Title
CN107648268B (zh) 磷虾油的胃肠外治疗应用
CN103200965B (zh) 使用ω-3脂肪酸作为肠胃外给药治疗的药物媒介以减少药物不良事件的方法
KR101503970B1 (ko) 오메가-3 풍부화된 비경구 영양 수중-어유 에멀전
CN102088978B (zh) 血脂异常症的改善或治疗药
KR102118478B1 (ko) 지방산 오일 혼합물 및 계면활성제를 포함하는 조성물, 및 이의 방법 및 용도
CN105120842B (zh) 包含脂质化合物、甘油三酯和表面活性剂的组合物以及使用它们的方法
JP2011006380A (ja) ω３脂肪酸の乳化組成物
US10052352B2 (en) Therapeutic application of parenteral krill oil
US9861605B2 (en) Enriched injectable emulsion containing selected fatty acid triglycerides
US8895074B2 (en) Therapeutic application of parenteral krill oil
CN105939706A (zh) 用于肠胃外给药的包含epa乙酯和dha乙酯的组合物
HK1244678B (en) Therapeutic application of parenteral krill oil
HK1244678A1 (zh) 磷虾油的胃肠外治疗应用
US20250248964A1 (en) Long-term efficacy of liver disease treatment with EPA and DHA
CN110139645A (zh) 用于预防和/或治疗恶病质的ω-3脂肪酸组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140226

RJ01 Rejection of invention patent application after publication